Cookson Peirce & CO Inc Sangamo Therapeutics, Inc Transaction History

Cookson Peirce & CO Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$1.11 - $1.74 $55,500 - $87,000	50,000 New	50,000 $65,000
Q3 2022 Nov 08, 2022	BUY	$4.27 - $6.39 $51,239 - $76,680	12,000 New	12,000 $59,000
Q1 2021 May 11, 2021	SELL	$10.88 - $17.05 $1.08 Million - $1.69 Million	-99,030 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$9.23 - $18.18 $914,046 - $1.8 Million	99,030 New	99,030 $1.55 Million
Q2 2018 Jul 26, 2018	SELL	$13.9 - $19.8 $384,335 - $547,470	-27,650 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$16.7 - $26.35 $41,917 - $66,138	2,510 Added 9.98%	27,650 $0
Q4 2017 Feb 12, 2018	SELL	$11.6 - $17.35 $244,296 - $365,391	-21,060 Reduced 45.58%	25,140 $0
Q3 2017 Nov 13, 2017	BUY	$8.4 - $15.0 $85,764 - $153,150	10,210 Added 28.37%	46,200 $0
Q2 2017 Aug 17, 2017	BUY	N/A	35,990	35,990 $0

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.